Progress in Cardiovascular Diseases

Progress in Cardiovascular Diseases is a bimonthly peer-reviewed medical journal covering cardiology, established in 1958 and published by Elsevier, with a 2025 impact factor of 10.6（Progress in Cardiovascular Diseases）是一本覆盖心脏病学的双月刊同行评审医学期刊，1958 年创刊并由（Elsevier）出版，2025 年影响因子为 10.6。

Scope

• The journal covers the understanding and treatment of disorders of the heart and circulation该刊涵盖心脏与循环系统疾病的理解与治疗。
• It publishes regular research articles and definitive reviews that capture the state of the art in the management of particular clinical problems in cardiology该刊发表常规研究论文与权威综述，呈现心脏病学特定临床问题管理的最新水平。
• Issues are occasionally focused on a single topic, so that a thematic issue can comprehensively cover one subject in the understanding and treatment of cardiovascular disorders部分期刊围绕单一主题组织，从而以专号形式全面覆盖心血管疾病理解与治疗中的某一专题。
• The subject area of the journal is cardiology and cardiovascular medicine该刊的学科领域为心脏病学与心血管医学。
• Article formats include research articles, review articles, editorials, and viewpoints文章形式包括研究论文、综述、社论与观点文章。
• Section editors coordinate coverage of coronary artery disease, cardiomyopathies, electrophysiology, cardiovascular imaging, artificial intelligence, prevention, and clinical trials各栏目编辑分别统筹冠状动脉疾病、心肌病、电生理学、心血管影像、人工智能、预防与临床试验等方向的稿件。

History

• The journal was established in 1958 by the W. B. Saunders Company, and the founding editor was the cardiologist Charles K. Friedberg of Mount Sinai Hospital该刊于 1958 年由（W. B. Saunders Company）创办，创刊主编为西奈山医院的心脏病学家（Charles K. Friedberg）。
• The W. B. Saunders imprint is based in Philadelphia in the United States and now operates within Elsevier（W. B. Saunders）出版机构设于美国费城，现隶属于（Elsevier）体系。
• Former editors listed by the journal include Henry Greenberg, Carl Lavie, Michael Lesch, and Edmund Sonnenblick该刊编委页列出的历任主编包括（Henry Greenberg）、（Carl Lavie）、（Michael Lesch）与（Edmund Sonnenblick）。
• Carl J. Lavie marked four years as editor-in-chief with a reflective editorial published in 2018（Carl J. Lavie）于 2018 年刊出一篇回顾性社论纪念其出任主编四周年。^[1]
• Lavie marked eight years in the role with a 2021 editorial before the editorship passed to new hands（Lavie）又于 2021 年刊出社论纪念其任职八周年，此后主编职务几经更替。^[2]
• The journal reached volume 96 by 2026, issuing six volumes per year, and its impact factor moved from 11.278 in 2022 to 7.6 in 2024 and 10.6 in 2025, while its CiteScore stands at 13.6该刊至 2026 年已出至第 96 卷，每年出版 6 卷，影响因子由 2022 年的 11.278 变为 2024 年的 7.6 与 2025 年的 10.6，（CiteScore）为 13.6。

Editors

• Leandro Slipczuk, MD, PhD, FACC, of Albert Einstein College of Medicine in New York is the Editor-in-Chief纽约（Albert Einstein College of Medicine）的（Leandro Slipczuk）医学博士、哲学博士、美国心脏病学会会士现任主编。
• Deepak Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, of the Icahn School of Medicine at Mount Sinai serves as Deputy Editor（Icahn School of Medicine at Mount Sinai）的（Deepak Bhatt）担任副主编。
• Fourteen section editors span the United States, Argentina, Finland, Italy, and Pakistan, including Martha Gulati on heart disease in women, Leslee J. Shaw on cardiovascular imaging, and Ahmad Masri on cardiomyopathy and heart failure十四位栏目编辑分布于美国、阿根廷、芬兰、意大利与巴基斯坦，包括负责女性心脏病的（Martha Gulati）、负责心血管影像的（Leslee J. Shaw）以及负责心肌病与心力衰竭的（Ahmad Masri）。
• Daniel Lorenzatti of Montefiore Einstein Hospital serves as social media editor（Montefiore Einstein Hospital）的（Daniel Lorenzatti）担任社交媒体编辑。
• Editorial board members are drawn from institutions across the United States, Canada, Argentina, and Italy, and the board page also records a Fellow in Training position编委成员来自美国、加拿大、阿根廷与意大利的机构，编委页另设（Fellow in Training）岗位。